PTJ
PRCT icon

Paul Tudor Jones’s Procept Biorobotics PRCT Stock Holding History

Paul Tudor Jones’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,100
Closed -$318K – 4146
2025
Q4 		$318K Buy
10,100
+1,600
+19% +$53.1K ﹤0.01% 3009
2025
Q3 		$303K Buy
+8,500
New +$388K ﹤0.01% 2971

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paul Tudor Jones's PRCT Position: Q2 2026 in Review

Paul Tudor Jones increased its Procept Biorobotics (PRCT) stake by 55% in Q2 2026, buying an estimated $1.51M and bringing the position to 169,727 shares worth $3.83M. The position accounts for 0.01% of the portfolio, ranked #1470.

Paul Tudor Jones first reported a position in PRCT in Q4 2021 and has held it in 5 quarters since. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Paul Tudor Jones held 169,727 shares of Procept Biorobotics worth $3.83M as of Q2 2026.
  • Paul Tudor Jones bought 60,178 Procept Biorobotics shares in Q2 2026, an estimated $1.51M.
  • Procept Biorobotics made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1470 holding.
  • Paul Tudor Jones first reported a position in Procept Biorobotics in Q4 2021 and has held it in 5 quarters since.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.